Here's what you need to know this week about artificial intelligence in the Bay Area: Google needs GPUs, OpenAI leads funding ...

A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing ...

Xaira Therapeutics today announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company's efforts to develop AI-driven models to help elucidate ...

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five years.

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Artificial intelligence is reshaping key sectors such as finance, pharmaceuticals, and manufacturing, yet its overall ...

According to Dealroom, in Q1 2025, European startups have secured $15.8B through nearly 1,600 funding rounds. From AI and fintech to clean energy and biotech, startups have attracted large amounts of ...